Angel Gurria, secretary general of the Organization for Economic Co-operation and Development (OECD): the OECD’s report suggests global FDI increased by 25 per cent to $1.7 trillion in 2015. Photograph: Molly Riley/AFP/Getty Images

Foreign direct investment (FDI) among top industrial countries almost doubled last year with large inflows recorded in Ireland, the Netherlands, Switz(...)

US treasury secretary Jack Lew said  the new restrictions would “further rein in inversions and reduce the ability of companies to avoid taxes”. Photograph: Andrew Harrer/Bloomberg

The US government has taken steps to crack down further on tax-avoiding corporate “inversion” deals involving American corporations merging with overs(...)

Medical device maker  Medtronic: the US industry giant moved to Ireland  in a tie-up estimated to be worth $48bn. Photograph: Munshi Ahmed/Bloomberg

A spate of so-called “tax inversion” deals involving companies based in Ireland appears to be distorting the country’s foreign direct investment (FDI(...)

Seagate’s spending put it in 126th place out of the top 2,500 companies in the world in the annual survey by the European Commission. Photograph: Paul Faith/PA Wire

A survey has found that Seagate Technology, an American data storage company, is the single biggest investor in research and development (R&D) in(...)

Botox is one of a number of pharmaceutical products made in Allergan’s Westport plant. Photograph: Shannon Stapleton/Files/Reuters

Allergan, the maker of Botox, has agreed to sell itself in a $66 billion (€53 billion) deal with fellow drugs group Actavis, with rival Valeant bowing(...)

A doctor injects a patient with Allergan’s Botox. Photographer: Patrick T. Fallon/Bloomberg

Botox maker Allergan, which is fending off an acquisition by Valeant Pharmaceuticals, said today that it had been approached by another party regardi(...)

Pfizer has yet to formally put a value on the Actavis bid as it says no actual offer has been made, but it does make for a complicated chain all the same.

Keeping track of the merry-go-round that is pharma M&A is quite a challenge. It’s not all down to corporate inversion – that bête noir of US polit(...)

 Pfizer has approached Actavis to express its interest in an acquisition that could allow the US drugmaker to move overseas and reduce taxes. Photo: Bloomberg

Ireland is back at the centre of the controversy over corporate inversion as it emerged that drug giant Pfizer has approached Irish-headquartered Acta(...)

M&A activity in Ireland is at its strongest since 2008 with 42 deals announced during the first half of the year, according to new figures compile(...)

The head offices of Valeant Pharmaceuticals  in Laval, Quebec. The Canadian-based company said Allergan’s refusal to enter talks left it with no option but to go hostile in the battle for control of its US rival. Photograph: Christinne Muschi/Reuters

Valeant Pharmaceuticals is preparing to take its bid for Allergan direct to shareholders after its latest $53 billion offer was rejected by the mak(...)